April 21, 2017: Celgene continues to expand its presence in one of the hottest biotech hubs of the U.S., Cambridge, MA. The NJ-based pharma company snapped up a 40,000 square-foot facility formerly occupied by Amgen.
April 21, 2017: Incyte is widely viewed as a hot property. In a study by Evercore ISI last year that surveyed 244 biotech industry observers, Incyte was cited as the top acquisition target.
April 21, 2017: Investors have fairly limited options for buying gene-sequencing companies-there just aren't that many to invest in. And some of the companies involved in gene sequencing aren't exclusively focused on it.
April 21, 2017: Biotech stocks can be volatile, but it’s possible to catch companies on the upswing or that have pending catalysts. SmarterAnalyst looks at two biotech companies that are likely on their way up.